The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis
<p>Abstract</p> <p>Background</p> <p>Chronic pancreatitis is characterized by progressive fibrosis, pain and loss of exocrine and endocrine functions. The long-standing chronic pancreatitis and its associated pancreatic fibrosis are the most common pathogenic events inv...
Main Authors: | Bai Han, Chen Xiaokai, Zhang Lin, Dou Xiaoguang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-230X/12/115 |
Similar Items
-
Sulindac Sulfide, but Not Sulindac Sulfone, Inhibits Colorectal Cancer Growth
by: Christopher S. Williams, et al.
Published: (1999-06-01) -
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
by: Jennifer S. Davis, et al.
Published: (2020-09-01) -
Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse
by: JULIO ILLANES, et al.
Published: (2002-01-01) -
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
by: Evrim eGurpinar, et al.
Published: (2013-07-01) -
NSAIDs: Old Drugs Reveal New Anticancer Targets
by: Gary A. Piazza, et al.
Published: (2010-05-01)